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Abstract
Natural Killer (NK) cells destroy (lyse) tumor cells, virally infected cells and antibody-coated cells.
Previous studies indicated that exposure to the environmental contaminant tributyltin (TBT)
decreases the lytic function of NK cells and activates mitogen activated protein kinases (MAPK),
including p44/42 (Aluoch and Whalen, 2005). If activation of p44/42 is required for TBT-induced
decreases of lytic function, then activation of p44/42 to similar extents by pharmacological agents
such as Phorbol 12-myristate 13-acetate (PMA) should mimic to some extent changes induced in
NK cells with TBT exposures. NK cells were exposed to PMA concentrations between 0.25 and 10
nM for 10 min, 1 h, and 6 h before determining the lytic function (51Cr release assay) and
phosphorylation state of MAPKs (Western blot). A 1 h exposure of NK cells to 5 nM PMA resulted
in a loss of lytic function of 47%. Western blot analysis showed that a 1 h exposure to 5 nM PMA
caused a 6 fold increase in phospho-p44/42 levels. Previous studies showed a 5 fold increase in
phospho-p44/42 in response to a 1 h exposure to 300 nM TBT. Exposure to 300 nM TBT caused
about a 40% decrease in lytic function. This study supports the hypothesis that p44/42 activation (as
seen with TBT exposures) can cause a loss of NK-cell lytic function.
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INTRODUCTION
Natural Killer (NK) cells are a subset of lymphocytes that are capable of killing tumor cells,
virally infected cells and antibody-coated cells. NK cells are defined by the absence of T cell
receptor/CD3 complex and by the presence of CD56 and/or CD16 on the cell surface. NK cells
are capable of killing the above target cells without prior sensitization, putting them in the
forefront of lymphocyte defense against tumor cells and virally infected cells (Lotzova,
1993, Vivier et al., 2004). The earliest and possibly predominant defense against tumor cells
has been attributed to NK cells (Lotzova, 1993; O’Shea and Ortaldo, 1992; Trinchieri, 1989).
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They are responsible for limiting the spread of blood borne metastases, as well as limiting the
development of primary tumors (Kiessling and Haller, 1978; Hanna, 1980). NK cells also play
a central role in immune defense against viral infection as evidenced by greatly increased
incidence of viral infection seen in individuals where the NK subset of lymphocytes is
completely absent (Fleisher et al, 1982; Biron et al, 1989).
Tributyltin (TBT) is a very significant environmental contaminant (Kimbrough, 1976;
Laughlin and Linden, 1985; Tanabe et al., 1998; Loganathan et al., 2000). TBT was mainly in
used in wood preservation, marine antifouling paints, disinfection of circulating industrial
cooling waters, and slime control in paper mills (Kimbrough, 1976; Roper, 1992; Yamada et
al., 1993). It has been found in various household products such as siliconized-paper baking
parchments and shower curtains (Yamada et al., 1993). TBT has been detected in human food,
such as fish (Kannan et al., 1995a,b,c). Due to the wide spread industrial and household
applications, it is not a surprise that TBT is found in human blood (Kannan et al., 1999; Whalen
et al., 1999).
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Previous studies indicated that exposure to TBT decreases the lytic function of NK cells
(Dudimah et al., 2007; Whalen et al., 1999), decreases their expression of cytolytic proteins
(granzyme B and perforin) (Thomas, et al., 2004; Thomas et al., 2005), and activates mitogen
activated protein kinases (MAPK), including p44/42 (Aluoch and Whalen, 2005; Aluoch et
al., 2006; Aluoch et al., 2007). TBT-induced loss of NK function could leave exposed
individuals with an increased risk of viral infection and /or tumor formation. We have recently
shown that activation of p44/42 was not the only factor involved in the mechanism of TBTinduced loss of lytic function (using p44/42 pathway inhibitors) (Abraha and Whalen, 2009).
However, it is still necessary to determine what role the activation of p44/42 play in the loss
of NK lytic function. If activation of p44/42 is required for any of these TBT-induced alterations
of NK cell function then pharmacological agents such as Phorbol 12-myristate 13-acetate
(PMA) that selectively activate p44/42 should mimic (to some extent) changes induced in NK
cells with TBT exposures.
The current study examined the effect of varying PMA concentrations on the activation state
of MAPKs. Experiments verifying the extent and selectivity of PMA activation of p44/42 in
NK cells were carried out. Additionally, concentrations of PMA that activate p44/42 to an
extent similar to that seen with TBT were examined for their ability to induce alterations of
cytotoxic function and cytolytic protein expression in NK cells that were similar to those with
TBT .

MATERIALS AND METHODS
NIH-PA Author Manuscript

Isolation of NK cells
Peripheral blood from healthy adults (male and female) volunteer donors was used for this
study. Buffy coats (source leukocytes) obtained from either the American Red Cross (Portland,
OR) or Key Biologics, LLC (Memphis, TN) were used to prepare NK cells. Highly purified
NK cells were obtained using a rosetting procedure. Buffy coats were mixed with 1 mL of
RosetteSep human NK cell enrichment antibody cocktail (StemCell Technologies, Vancouver,
British Columbia, Canada) per 45 mL of buffy coat. The mixture was incubated for 20 min at
room temperature (∼ 25º C). Following the incubation, 5–8 mL of the mixture was layered
onto 4 mL of Ficoll-Hypaque (1.077 g/mL) (MP Biomedicals, Irvine, CA) and centrifuged at
1200 g for 30–45 min. The cell layer was collected and washed twice with phosphate buffered
saline (PBS) pH 7.2 and stored in complete media (RPMI-1640 supplemented with 10% heatinactivated BCS, 2 mM L-glutamine and 50 U penicillin G with 50 µg streptomycin/mL
(Mediatech, Inc. Herndon, VA)) at 1 million cells/mL. The resulting cell preparation was >95%
CD16+, 0% CD3+ by fluorescence microscopy (Whalen et al., 2002).
Cell Biol Toxicol. Author manuscript; available in PMC 2011 October 1.
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Chemical preparation

NIH-PA Author Manuscript

PMA was dissolved in dimethylsulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO) to give 10
mM stock solution. A 10 mM stock of anisomycin was also prepared in DMSO. Desired
concentrations of the compound were prepared by dilution of the stock into complete media
containing 0.5% gelatin in place of the 10% bovine serum. Gelatin replaced BSA to avoid
binding of the hydrophobic compounds to serum albumin, which could interfere with their
delivery of the cells. The final concentration of DMSO did not exceed 0.01%.
Cell Treatments—Purified NK cells were separated by centrifugation from complete media
(defined above) and transferred to complete media containing 0.5% gelatin in place of the 10%
bovine serum. As mentioned above, this was done in order to avoid binding of the hydrophobic
compounds to serum albumin, which could interfere with their delivery to the cells. NK cells
(at a concentration of 1.5 million cells/ mL) were then exposed to the compound or control for
varying lengths of time (10 min, 1 h, 6 h, or 24 h). Following the exposure the cells were
assayed for tumor-destroying function or lysed for Western Blot analysis. Additionally, NK
cells were exposed to compounds for 1 h; following the 1 h exposure period, the compoundcontaining or control media was removed and replaced with fresh compound-free media and
the cells were incubated in compound-free media for 24 h before assaying for lytic function.
The concentration ranges examined for the compound were: 0.25 nM to 10 nM for PMA and
0.5 µM to 10 µM for anisomycin.
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Cell Viability
Cell viability was determined by trypan blue exclusion. Cell numbers and viability were
assessed at the beginning and end of each exposure period. Viability was determined at each
concentration for each of the exposure periods. The viability of treated cells was compared to
that of control cells at each length of exposure (Whalen et al., 2003).
Cytotoxicity assay
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The ability of NK cells to lyse tumor cells was measured using a 51Cr release assay (Whalen
et al., 1999; Whalen, 1997). The target cell in all cytotoxicity assays was the NK-susceptible
K562 (human chronic myelogenous leukemia) cell line. K562 cells were incubated with 51Cr
(Perkin-Elmer Life Sciences, Boston, MA) in 0.2–0.5 ml of BCS for 1–1.5 h at 37 °C in air/
CO2 (19:1). Following this incubation the target cells were washed twice with gelatin media.
NK (effector) cells (1.2×105/100 µL for 12:1 ratio with target cells) were added to the wells
of round-bottom microwell plates. The effectors were diluted to 6:1 ratio (0.6×105/100 µL)
and 3:1 ratio (0.3×105/100 µL); each ratio was tested in triplicate. Target cells were added
(1×104/100µL) to each well of the microwell plate and the plate was centrifuged at 300g for
3.5 min and incubated for 2 h at 37 °C (air/CO2, 19:1). After incubation a 0.1 ml aliquot of the
supernatant was collected and counted for radioactivity for 60 sec in a Packard COBRA gamma
radiation counter (Packard Instrument Co., Meriden, CT). Target lysis was calculated as
follows: 100x[(test c.p.m - spontaneous c.p.m.)/maximum c.p.m.- spontaneous c.p.m.)].
Maximum release was produced by adding 100 µL of 10% Triton X-100.
Cell lysates
NK cells at a concentration of 6 million/mL were exposed to compounds (PMA and
anisomycin) as described above. Following the treatments, the cells were centrifuged and the
cell pellets were lysed using 133 µL of lysis buffer (Active motif, Carlsbad, CA) per 2 million
cells. The cell lysates were stored frozen at −80 °C up to the point when they were run on SDSPAGE. Control and treated cells for a given experimental setup (described above) were from
an individual donor (Aluoch and Whalen, 2005).
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Western Blot
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Cell lysates were run on 10% SDS-PAGE (sodium dodecylsulfate polyacrylamide gel
electrophoresis) membrane. The PVDF was immunoblotted with anti-phospho p38 (Thr180
and Tyr182), anti-p38, anti-phospho-p44/42 (Thr202/Tyr204), anti-p44/42, anti-phosphoSAPK/JNK (Thr183 and Tyr185), anti-SAPK/JNK, and anti-β-actin antibodies (Cell signaling
Technologies, Beverly, MA). Antibodies were visualized using ECL chemiluminescent
detection sytem (Amersham, Piscataway, NJ) and Kodak Image Station (Kodak, Rochester,
NY). The density of each protein band was determined by densitometric analysis using the
Kodak Image Station analysis software. The settings on the image station were optimized to
detect the largest possible signal range and prevent saturation of the system. Differences in
protein expression are determined relative to an internal control. This determination provides
relative quantitation by evaluating whether a given treatment changed expression of phosphop44/42, p44/42, phospho-p38, p38, phospho-SAPK/JNK, or SAPK/JNK, relative to untreated
cells. β-actin levels were determined for each condition to verify that equal amounts of protein
were loaded. In addition, the density of each protein band was normalized to β-actin to correct
for small differences in loading among the lanes.
RNA isolation and real-time quantitative RT-PCR
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Human NK cells were isolated from whole blood as described in the section under NK cell
isolation, treated with the compounds of interest for the desired lengths of time before
proceeding with total RNA extraction. Total RNA was extracted using an RNeasy mini kit
(Qiagen; Valencia, CA) and its concentration determined by reading the optical density at 260
nm. Possible genomic DNA contamination was removed by on-column DNase digestion using
the RNase–free DNase set. Two million NK cells per treatment condition were used. Samples
were diluted in RNase-free water to 15 ng/uL and stored in micro-centrifuge tubes at −80 ºC.
Real-time quantitative RT-PCR (qRT-PCR) was performed with an iCycler iQ System. Primers
were designed using Primer Express 2.0 software (ABI). Primers were designed in such a way
that they included at least one intron-exon junction so as to increase the specificity for the target
genes and to minimize the amplification of closely related genes. Genes of interest were
compared to closely related genes using BLAST and primers were designed based on divergent
regions of the target gene sequence compared to those of the highly related genes. The
QuantiTect SYBR green RT-PCR kit (Qiagen) and gene-specific PCR primers were used in a
20 µL reaction following protocols recommended by the manufacturer. To ensure that there is
no significant difference in the concentration of total RNA in each sample, 18s RNA was
analysed by qRT-PCR.
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Generally, the PCR mixture (20 µL) contained 30 ng of total RNA and 0.2 µM each primer,
10 nM fluorescein calibration dye, 0.2 µL RT mix and 10 µL of 2× master mix. . Reverse
transcription was performed for 20 min at 50 °C, followed by amplification for 35 cycles (15
s at 94 °C, 60 s at 60 °C) after an initial activation at 95 °C for 15 min. Melting curve analysis
was carried out to determine the specificity of amplification. Analysis of results was done using
the comparative Ct method. This involves comparing the Ct values of the samples of interest
with a control or calibrator such as a non-treated sample. The comparative Ct method is also
known as the delta Ct method, where [delta]Ct = [delta]Ct,sample - [delta]Ct,reference where
[delta]Ct,sample is the Ct value for any treated sample and [delta]Ct, reference is the Ct value for
the calibrator or untreated sample. The mRNA levels were represented in arbitrary units.
Statistical Analysis
Statistical analysis of the data was carried out utilizing ANOVA and Student's t test. Data were
initially compared within a given experimental setup by ANOVA. A significant ANOVA was
followed by pair wise analysis of control versus exposed data using Student’s t test.
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RESULTS
Effects of 1 h exposures to PMA on NK lytic function

NIH-PA Author Manuscript

In order to combine results from separate experiments (using cells from different donors) the
tumor lysis caused by treated cells was normalized to that of control cells in a given experiment.
The concentrations of PMA used in the 1 h exposure ranged from 0.25–10 nM. NK cells
exposed to concentrations of 0.5 and 0.25 nM PMA showed a 15% decrease in lytic function
(Figure 1, black bars) (p<0.05). Exposure to 1 nM PMA for 1 h resulted in an approximately
36% loss of lytic function (Figure 1, black bars) (p<0.05). Concentrations of 10 nM and 5 nM
resulted in a 47% reduction of cytotoxic function (p<0.05).
Effects of 1 h exposures to PMA followed by 24 h in PMA-free media on NK lytic function
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NK cells were exposed to PMA (0.5–10 nM) for 1 h. Following this exposure the PMA was
removed the cells were incubated in PMA-free media for 24 h prior to assaying for lytic
function. Previous studies have shown that a 1 h exposure to TBT results in a progressive loss
of lytic function 24 h after removal of the compound (Dudimah et al. 2007; Whalen et al.,
2002). A 1 h exposure of NK cells to concentrations of 2.5, 5, and 10 nM PMA resulted in a
loss of lytic function of approximately 46% 24 h after the removal of the PMA (p<0.004)
(Figure 1, gray bars). The 1 nM concentration resulted in a 25% loss of cytotoxic function
whiles the 0.5 nM concentration led to a loss of lytic function by about 14% (p< 0.004)
compared to the control (Figure 1, gray bars).
Effects of 10 min, 1 h, and 6 h exposures to PMA on the phosphorylation state of p44/42 in
NK cells
Exposure of human NK cells to concentrations of PMA ranging between 0.5 and 10 nM for
10 min resulted in observable increases in phosphorylation of p44/42. However, only
concentrations of 2.5, 5, and 10 nM resulted in a statistically significant increases in phosphop44/42 of 9.9±5.2, 12.4±4.8, and 17.2±6.6, respectively (p<0.05) (Figure 2A, black bars).
There were no significant changes in the levels of total p44/42. Figure 2B shows results from
a representative experiment for the 10 min exposure to PMA.
A 1 h exposure of NK cells to PMA also caused significant increases in the phosphorylation
of p44/42 MAPK (p<0.05). 5 nM PMA increased phospho-p44/42 by 6.3±1.7 fold, while 10
nM PMA caused 6.8±0.7 fold increase in phosphorylation of p44/42 (Figure 2A, dark gray
bars). Again, total p44/42 was unaffected by PMA. Figure 2C shows results from a
representative 1 h experiment.
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Following a 6 h exposure to PMA, there were significant increases in phosphorylation of p44/42
at 1, 2.5, 5, and 10 nM PMA (p<0.05). Concentrations of 2.5,5, and 10 nM PMA all caused
over 25 fold increases in phospho-p44/42 levels, whereas the 1 nM concentration resulted in
a 13.9 fold increase in phospho-p44/42 (Figure 2A, light gray bars). There was no change in
the level of total p44/42. Figure 2D shows results from a representative experiment at 6 h.
Effects of 10 min, 1 h, and 6 h exposures to PMA on the phosphorylation states of p38 and
JNK
Exposure of human NK cells to various concentrations of PMA for 10 min did not result in
any observable change in the phosphorylation state of p38 or JNK compared to the controls
(Figure 3). Exposure of NK cells to PMA for 10 min did not affect the total levels of the above
mentioned MAPKs either (Figure 3).
Neither 1 h nor 6 h exposures of human NK cells to PMA caused any significant changes in
the phosphorylation of either p38 or JNK, or in their total levels (data not shown).
Cell Biol Toxicol. Author manuscript; available in PMC 2011 October 1.
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Effects of 24 h exposures to PMA on the levels of granzyme B and perforin in NK cells
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NK cells exposed to concentrations of PMA ranging from 0.5–10 nM for 1, 6, or 24 h showed
no decrease in the levels of granzyme B or perforin as compared to control cells. Figure 4
shows a representative experiment. In studies examining the effects of a 24 h exposure to TBT
on granzyme and perforin protein levels, granzyme B levels were decreased by 51±27% and
perforin levels were decreased by 47±24% (Thomas et al., 2004).
Effects of Anisomycin on the activation state of MAPKs, lytic function, and expression of
cytolytic proteins in NK cells
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Previous studies with TBT have shown that there was also a significant activation of p38 MAPK
when NK cells were exposed to TBT (Aluoch and Whalen, 2005; Aluoch et al., 2006). This
activation was approximately 2 fold when NK cells were exposed to 300 nM TBT for 10 min
and maintained out to 6 h. Thus, in order to investigate the potential role of p38 activation in
TBT-induced loss of function, NK cells were exposed to anisomycin, which is among other
things an activator of p38 (Shifrin and Anderson, 1999). When NK cells were exposed to
anisomycin for 1 h, only the 10 µM concentration caused a significant activation of p38 of
about 1.5 fold (p<0.05), it did not significantly activate other MAPKs. Figure 5B is a
representative experiment showing increased phosphorylation of p38 with exposure to 10 µM
anisomycin for 1 h. The same treatment caused no significant decrease in NK lytic function
when lytic function was tested immediately after the 1 h exposure to anisomycin (Figure 5A).
However, if the anisomycin was removed after the 1 h exposure and the cells were incubated
for 24 h in anisomycin-free media before testing for lytic function, there was a small decrease
in lytic function of 14±12% (p<0.0001) (Figure 5A). However, if NK cells were treated with
1 µM anisomycin for 24 h they lost 88±11% of their lytic function (p<0.0001) (Figure 5A).
Since anisomycin is known to interfere with protein synthesis, its effects on granzyme and
perforin expression were examined at the level of mRNA levels. RT-PCR results showed a
remarkable reduction in the levels of granzyme B mRNA of anisomycin treated cells compared
to control cells (Figure 5C). Both the 2.5 µM and 10 µM treatments resulted in significantly
lowered levels of mRNA expression (P<0.02 in both cases). The exposure of human NK cells
to anisomycin for 24 h also resulted in a significant reduction in the expression of perforin
mRNA (Figure 5C). Additionally, the mRNA levels of peptidylprolyl isomerase B (PPIB) were
also very significantly decreased with anisomycin exposure.

DISCUSSION
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The main goal of this study was to determine what role the activation of p44/42 plays in the
TBT-induced loss of NK lytic function. We have previously shown that TBT exposures that
cause a loss of NK lytic function were able to activate p44/42 (Aluoch and Whalen , 2005,
Aluoch et al., 2006, Aluoch et al., 2007). We have also shown that the activation of p44/42 is
not solely responsible for the loss of NK cell function as specific inhibitors of p44/42 activation
cannot block the negative effects of TBT (Abraha and Whalen, 2009). This is likely due to the
fact that TBT causes additional changes in NK cells, such increases in cytosolic calcium ion
concentrations (Lane et al., 2009). However, in order to understand the mechanism(s) by which
TBT interferes with NK cell function, it is important to define the role played by p44/42
activation as it is an important consequence of TBT exposure in NK cells. By selectively
activating p44/42 with Phorbol 12-myristate 13-acetate (PMA) and monitoring NK cell
function, we will begin to determine the contribution that p44/42 activation makes to the TBTinduced loss of lytic function.
The results indicated that exposure of human NK cells to PMA concentrations of −0.25–10
nM for 1 h caused a significant loss in their ability to lyse tumor cells. Additionally when NK
cells were exposed to PMA for 1 h followed by 24 h in compound-free media they showed a
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persistent loss of lytic function. These results are similar to what we have previously seen when
NK cells were exposed to TBT for 1 h or for 1 h followed by a 24 h period in TBT-free media
(Figure 1, Dudimah et al., 2007;Whalen et al., 2002).
The activation state of p44/42 was also determined at the same concentrations of PMA where
loss of lytic function was seen. We have shown previously shown that TBT exposures for 1 h
caused significant activation of p44/42 (Aluoch and Whalen, 2005. Aluoch et al., 2006). Very
significant activation of the MAPK, p44/42, was seen within 10 min of exposure of human NK
cells to PMA concentrations of 2.5, 5, and 10 nM (9.9, 12.4, and 17.2 fold, respectively) with
neither p38 nor JNK being activated. An increase in phospho-p44/42 was also seen in NK cells
exposed to these same concentrations of PMA for 1 h, however the fold increase at 1 h is
somewhat lower that seen at 10 min (4.8, 6.3, and 6.8 fold increases, respectively). These results
suggest that activation of p44/42 may result in loss of NK lytic function. The fact that the level
of phospho-p44/42 observed after 1 h is lower than that observed after 10 min, could be as a
result of phosphatase activity occurring between the 10 minute and 1 h time period. However,
it appears that this phosphatase activity may fluctuate, since a 6 h exposure of NK cells to PMA
concentrations of 1, 2.5, 5 and 10 nM caused much greater increases in phospho-p44/42 levels
than were seen at 1 h (13.8, 26.8, 27.7, and 25.3 fold, respectively).
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As mentioned earlier, previous studies have shown that exposure of NK cells to TBT decreases
their lytic function (Dudimah et. al., 2007) and activates the MAPK, p44/42 (Aluoch and
Whalen, 2005; Aluoch et. al., 2006; Aluoch et al., 2007). Here we show that an activation of
p44/42 of roughly 6–7 fold by 5 or 10 nM PMA (1 h ) causes an approximately 47% loss of
lytic function (Figure 1). When NK cells were exposed to 300 nM TBT for 1 h there was an
approximately 5 fold activation of p44/42 and an approximately 40–50% loss of lytic function
(Figure 1) (Dudimah et al., 2007; Aluoch and Whalen 2005). As mentioned above PMA is
selectively activating p44/42 in NK cells, thus it appears that the activation of p44/42 by either
PMA or TBT of 5–7 fold may be causing an approximately 50% loss of NK lytic function.
This allows us to make an estimate of the contribution of p44/42 activation to the overall loss
of lytic function seen with TBT exposure.
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When we examined whether activation of p44/42 by PMA could decrease expression of the
cytolytic proteins found in NK cells, granzyme B and perforin, we saw no PMA-induced
change in their levels of expression. Thus, the decreases in granzyme B and perforin expression
seen with exposures to TBT (Thomas et al., 2004; and Thomas et al., 2005) cannot be explained
by TBT-induced activation of p44/42, in contrast to the TBT-induced effects on lytic function.
This indicates that other TBT-induced changes, such as p38 activation (Aluoch and Whalen,
2005; Aluoch et al.,2006) or increases in cytosolic calcium ion (Lane et al., 2009), may be
responsible for the decreases seen in these proteins.
Because we have previously also seen significant increases (approximately 2 fold) in the
activation of the MAPK, p38, with TBT exposures (Aluoch and Whalen, 2005, Aluoch et al.,
2006), we attempted to address the possible contributions that activation of p38 has in the TBTinduced loss of NK function using the p38 selective activator, anisomycin (Shifrin and
Anderson, 1999). However, in addition to potentially activating p38, anisomycin is also able
to block translation by inhibiting the peptidyl transferase reaction (Middlebrook and
Leatherman, 1989). Thus, interpreting the results of anisomycin treatment of NK cells was
complicated by the fact that longer term effects such as those seen at 24 h of exposure could
be attributed to the translational effects rather than p38-activating effects of anisomycin.
However we were able to determine that anisomycin could cause a very small activation of
p38 about 1.5 fold at 1 h of exposure. We also found that this exposure could cause a small but
significant loss of lytic function when the cells were tested for lytic function following a 24 h
period in anisomycin-free media. This result indicated that anisomycin may be activating a
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process, such as transcriptional changes due to p38 activation, that does not immediately affect
NK lytic function but takes several hours to occur. We went on to examine whether anisomycin
treatment of NK cells could cause a decrease in the levels of the NK cytolytic proteins,
Granzyme B and perforin, as these two proteins are decreased by TBT exposure. We found
that anisomycin did cause a decrease in both granzyme B and perforin mRNA levels. Granzyme
B has been shown to have a binding site for the transcription regulator, AP-1 (which can be
activated by p38), in its promoter region (Hanson et al., 1993 )
In summary the results of the current study indicate that activation of p44/42 by TBT could be
a contributing factor to the loss of lytic function seen with TBT exposures as a selective
activation of p44/42 by PMA is able to cause losses of function similar to those seen when
p44/42 was activated by TBT. Additionally, they indicate that the decreases in lytic proteins
seen with TBT exposures could not be attributed to TBT-induced activation of p44/42.
However, as TBT is also known to activate other MAPKs in NK cells it may be that the effects
on protein expression were mediated through activation of p38, which also occurs but to a
lesser extent. Experiments using anisomycin to activate p38 were complicated in their
interpretation by the fact that anisomycin has other cellular effect beyond activation of p38.
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Figure 1.

Effects of exposures to PMA on the ability of NK cells to lyse tumor cells. NK cells were
exposed to 0.25–10 nM PMA or 300 nM TBT for 1 h (black bars) or exposed to 0.5–10 nM
PMA or 300 nM TBT for 1 h followed by a 24 h period in PMA-free media prior to assaying
for NK lytic function (gray bars): To combine results from separate experiments (using cells
from different donors) the levels of lysis were normalized as the percentage of the lytic function
of the control cells in a given experiment. Values are mean±S.D. from four separate
experiments using different donors (triplicate determinations for each experiment, n = 12). An
asterisk indicates a significant decrease as compared to control (p<0.05).
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Figure 2.

Effects of exposures of human NK cells to PMA on the phosphorylation state of p44/42. A)
Fold increase in phospho-p44/42 as compared to control cells following 10 min (black bar), 1
hour (dark gray bar), and 6 hour (light gray bar) exposures to varying concentrations of PMA
or to 300 nM TBT. Values are mean ±S.D. from at least three separate experiments using
different donors (triplicate determinations for each experiment, n ≥ 9). An asterisk indicates a
significant increase as compared to control (p<0.05). B) Representative western blot of the
effect of 10 min exposures of NK cells to PMA on the phosphorylation state of p44/42. C)
Representative western blot of the effect of 1 h exposures of NK cells to PMA on the
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phosphorylation state of p44/42. D) Representative western blot of the effect of 6 h exposures
of NK cells to PMA on the phosphorylation state of p44/42.
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Figure 3.

The effect of 10 min exposures of human NK cells to PMA on the phosphorylation states of
p38 and JNK. The exposures did not cause any significant changes in the levels of total p38,
phospho-p38, total JNK, or phospho-JNK.
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Figure 4.

The effect of 24 h exposures of human NK cells to PMA on the expression of the cytolytic
proteins, granzyme B and perforin.
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Figure 5.

Effect of exposures of human NK cells to anisomycin on: A) lytic function of NK cells. Values
are mean ±S.D. from at least three separate experiments using different donors (minimum of
triplicate determinations for each experiment, n ≥ 9 for 1 h exposure followed by 24 h period
in anisomycin-free media n=21). An asterisk indicates a significant decrease as compared to
control. B) phospho-p38 levels, representative experiment. C) the expression of granzyme B,
perforin and PPIB mRNA. Values are mean±S.D. of four different samples from different
donors. A significant difference in the expression of mRNA in treated cells compared to their
respective controls is indicated by an asterisk. The viability of anisomycin treated cells was
identical to that of control cells.
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Table 1

Quantitative RT-PCR (TaqMan) Primers
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Gene

Primer Sequence

Amplicon Size (bp)

Forward 542F TCGAGGCCCTGTAATTGGAA
18S RNA

71
Reverse 602R CCCTCCAATGGATCCTCGTT
Forward 68F TGCAACCAATCCTGCTTCTG

Granzyme

67
Reverse 134R CCGATGATCTCCCCTGCAT
Forward 1638F CTCCTTGGCACCTGTGATCAG

Perforin

69
Reverse 1706R GCCATGATTCAGGTTGCATCT
Forward 247F GCTGCCGGGACCTTCTG

Peptidylprolyl isomerase B (PPIB)

101
Reverse 347R CCCGGCCTACATCTTCATCTC
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